MedTrace Logo

Disability Case Manager: Full Member of the Revalidation Team

NCT03996798 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2021-01-22

No results posted yet for this study

Summary

The first 4-6 months after an incident which caused a handicap or chronic disease, it is important to involve and motivate patients to return to work. After this period, there is a major decrease on successful vocational reintegration. To facilitate vocational rehabilitation a Disability Case Manager (DCM) may play a major role. The DCM will act as key figure between the patient, the multidisciplinary team of the revalidation centre, the employers and other back-to-work services. There is need to provide evidence on the value of this program. The aim of this study is to test the added value of including a DCM in the classic revalidation trajectory, who will focus on early vocational and/or social rehabilitation.

Conditions

  • Vocational Rehabilitation

Interventions

OTHER

Disability Case Manager

The DCM will act as key figure between the patient, the multidisciplinary team of the revalidation centre, the employers and other back-to-work services in order to increase vocational reintegration after an incident which caused a handicap or chronic disease.

Sponsors & Collaborators

  • Jessa Hospital

    collaborator OTHER

  • Revalidatie & MS Centrum Overpelt

    collaborator OTHER

  • RIZIV

    collaborator UNKNOWN

  • PXL University College

    lead OTHER

Principal Investigators

  • Annemie Spooren, PhD · PXL University College

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
62 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2020-06-30
Completion
2020-09-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03996798 on ClinicalTrials.gov